| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AP1M1
|
adaptor-related protein complex 1, mu 1 subunit
|
|
API5
|
apoptosis inhibitor 5
|
|
APOB
|
apolipoprotein B
|
|
AR
|
androgen receptor
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
BCR
|
breakpoint cluster region
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
EDN1
|
endothelin 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
GH1
|
growth hormone 1
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRS4
|
insulin receptor substrate 4
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LYRM1
|
LYR motif containing 1
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MIR126
|
microRNA 126
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR148A
|
microRNA 148a
|
|
MIR152
|
microRNA 152
|
|
MIR23A
|
microRNA 23a
|
|
MIR96
|
microRNA 96
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PAX4
|
paired box 4
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIN4
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
TNF
|
tumor necrosis factor
|
|
TSC2
|
tuberous sclerosis 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
